Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone-Vilanterol for Mild Asthma
NCT04265105Phase 3Completed
- Sponsor
- RCSI Medical University of Bahrain
- Start
- Dec 2021
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone, vilanterol in asthma, sponsored by RCSI Medical University of Bahrain. Started Dec 2021; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04265105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04265105.